Moderna stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return.

Researchers at MIT have just developed a new lipid nanoparticle that super-enhances the effectiveness of the mRNA vaccine in ...

New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.

Donald Trump's health is once again being scrutinised after recent reports revealed that he received three mRNA vaccinations ...

Fintel reports that on November 10, 2025, B of A Securities maintained coverage of Moderna (NasdaqGS:MRNA) with a ...

The study was published in Nature Biotechnology last month and marks a shift in scientists’ understanding of how to ...

细胞治疗领域正面临多条技术路径的比较——“通用型”与“体内制备”之争，以及“病毒载体”与“LNP递送”之选。其中，基于LNP递送mRNA在体内生成靶向CD19 ...

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: a precisely timed mRNA shot could help many cancer patients live longer.

RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the ...

Q3 earnings beat estimates but pipeline setback and lower 2025 guidance raise concerns. Full analysis of results and outlook.

A new lipid nanoparticle could make mRNA vaccines more powerful and potentially lower the cost per vaccine dose.

Revaccination with mRNA-1345 against RSV at 12 months was noninferior to primary vaccination among adults aged 50 years and older.